“The arrival of this unprecedented ‘alien’ life form could in time have far-reaching ethical, legal and regulatory implications,”
Scientists reported Wednesday that they had taken a significant step toward altering the fundamental alphabet of life — creating an organism with an expanded artificial genetic code in its DNA.
The accomplishment might eventually lead to organisms that can make medicines or industrial products that cells with only the natural genetic code cannot.
The scientists behind the work at the Scripps Research Institute have already formed a company to try to use the technique to develop new antibiotics, vaccines and other products, though a lot more work needs to be done before this is practical.
The work also gives some support to the concept that life can exist elsewhere in the universe using genetics different from those on Earth.
“This is the first time that you have had a living cell manage an alien genetic alphabet,” said Steven A. Benner, a researcher in the field at the Foundation for Applied Molecular Evolution in Gainesville, Fla., who was not involved in the new work.
But the research, published online by the journal Nature, is bound to raise safety concerns and questions about whether humans are playing God. The new paper could intensify calls for greater regulation of the budding field known as synthetic biology, which involves the creation of biological systems intended for specific purposes.
“The arrival of this unprecedented ‘alien’ life form could in time have far-reaching ethical, legal and regulatory implications,” Jim Thomas of the ETC Group, a Canadian advocacy organization, said in an email. “While synthetic biologists invent new ways to monkey with the fundamentals of life, governments haven’t even been able to cobble together the basics of oversight, assessment or regulation for this surging field.”
Despite the great diversity of life on Earth, all species, from simple bacteria to human beings, use the same genetic code. It consists of four chemical units in DNA, sometimes called nucleotides or bases, that are usually represented by the letters A, C, G and T. The sequence of these chemical units determines what proteins the cell makes. Those proteins in turn do most of the work in cells and are required for the structure, function and regulation of the body’s tissues and organs.
The Scripps researchers chemically created two new nucleotides, which they called X and Y. They inserted an X-Y pair into the common bacterium E. coli. The bacteria were able to reproduce normally, though a bit more slowly than usual, replicating the X and Y along with the natural nucleotides.
In effect, the bacteria have a genetic code of six letters rather than four, perhaps allowing them to make novel proteins that could function in a completely different way from those created naturally.
“If you have a language that has a certain number of letters, you want to add letters so you can write more words and tell more stories,” said Floyd E. Romesberg, a chemist at Scripps who led the work.
Dr. Romesberg dismissed concern that novel organisms would run amok and cause harm, saying the technique was safe because the synthetic nucleotides were fed to the bacteria. Should the bacteria escape into the environment or enter someone’s body, they would not be able to obtain the needed synthetic material and would either die or revert to using only natural DNA.
The Latest on: Synthetic biology
via Google News
The Latest on: Synthetic biology
- Twist Bioscience Launches Industry-Leading NGS Methylation Detection System for Liquid Biopsy Cancer Analysis and Epigenetic Studieson February 25, 2021 at 12:53 am
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the ...
- Fate Therapeutics Inc (FATE) Q4 2020 Earnings Call Transcripton February 25, 2021 at 12:30 am
Q4 2020 Earnings CallFeb 24, 2021, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to the Fate Therapeutics Fourth Quarter 2020 ...
- Amyris Announces Launch of Pipette® Clean Baby Care Brand in Target Retail Stores Across North Americaon February 24, 2021 at 5:00 am
Amyris, Inc., a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today ...
- AbSci Receives Strategic Investment From Merck Global Health Innovation Fundon February 24, 2021 at 1:41 am
AbSci, a Vancouver, Wash.-based synthetic biology company that unifies biologic drug discovery and development processes, received a strategic equity investment from Merck Global Health Innovation Fun ...
- Scientists create new class of “Turing patterns” in colonies of E. colion February 23, 2021 at 3:10 pm
Now a team of Spanish scientists has managed to tweak E. coli in the laboratory so that the colonies exhibit branching Turing patterns, according to a recent paper published in the journal Synthetic ...
- New Technology Enables Predictive Design of Engineered Human Cellson February 23, 2021 at 7:02 am
One of the most exciting frontiers in medicine is the use of living cells as therapies. Using this approach to treat cancer, for example, many patients have been cured of previously untreatable ...
- Paragon Biosciences Appoints Jordan Dubow as Chief Medical Officeron February 23, 2021 at 6:01 am
With continued growth in its portfolio of life science companies, Paragon Biosciences announced the appointment of Jordan Dubow, M.D., as chief medical officer. Dr.
- Synthetic biology company, Camena Bioscience, expands presence at Chesterford Research Parkon February 23, 2021 at 2:17 am
Camena Bioscience has been based at Chesterford Research Park since its incorporation. The company’s multi-enzymatic technology, called gSynth™, has dramatically improved the accuracy of DNA synthesis ...
- Cancer Can Now Be Treated Using Living Cells And Synthetic Biology, Researchers Findon February 22, 2021 at 9:29 pm
Researchers have developed a process that uses parts from a very different kind of toolkit to build complex genetic circuits for cellular engineering. Read here ...
- Synthetic Biology Market Insights By Revenue, Upcoming Trends And Worldwide Players Foresights Till 2027 | By ARCon February 16, 2021 at 10:23 pm
The global synthetic biology market is expected to grow at noteworthy CAGR around 26.4 % throughout the forecast period and reach around US$ 14 billion by 2026. The Synthetic Biology Market is highly ...
via Bing News